Loomis expands its Pharma business by acquiring Kipfer-Logistik
Kipfer-Logistik is a logistics company based in
Loomis has been offering the transportation of pharmaceutical products in temperature-controlled environments on a smaller scale in
"This acquisition accelerates the growth of Loomis Pharma by integrating a well-established Swiss logistics company specializing in high-security and temperature-controlled road freight transport. Together, we will provide our customers with an even more comprehensive range of services, thereby strengthening our market position," says Aritz Larrea, President and CEO of Loomis.
The acquisition is expected to be accretive to the Group's operating profit (EBITA1) and the earnings per share for 2025.
1) Earnings Before Interest, Taxes, Amortization of acquisition-related intangible fixed assets, Acquisition-related costs and revenue and items affecting comparability.
This press release is also available on the company's website, www.loomis.com.
For more information, please contact:
Jenny Boström
Head of Sustainability and IR
[email protected]
+46 79 006 45 92
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Loomis expands its Pharma business by acquiring Kaspar |
View original content:https://www.prnewswire.com/news-releases/loomis-expands-its-pharma-business-by-acquiring-kipfer-logistik-302513295.html
SOURCE Loomis AB
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
- ET Global Named a 2026 Metro Atlanta Top Workplace by Axios
- Flexsys Narrows 6PPD Replacement to Two Final Molecules and Enters Cooperative Research and Development Agreement with U.S. Geological Survey for Independent Toxicity Testing
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share